Insights into the Antimicrobial Resistance Profile of a Next Generation Probiotic Akkermansia muciniphila DSM 22959
- PMID: 35954507
- PMCID: PMC9367757
- DOI: 10.3390/ijerph19159152
Insights into the Antimicrobial Resistance Profile of a Next Generation Probiotic Akkermansia muciniphila DSM 22959
Abstract
Akkermansia muciniphila is a Gram-negative intestinal anaerobic bacterium recently proposed as a novel probiotic candidate to be incorporated in food and pharmaceutical forms. Despite its multiple health benefits, the data addressing its antimicrobial susceptibility profile remain scarce. However, the absence of acquired resistance in probiotic strains is a compulsory criterion for its approval in the qualified presumption of safety list. This study aimed at characterizing the A. muciniphila DSM 22959 strain's antimicrobial susceptibility profile using phenotypic and in silico approaches. To establish the phenotypic antimicrobial susceptibility profile of this strain, minimum inhibitory concentrations of eight antimicrobials were determined using broth microdilution and E-test methods. Additionally, the A. muciniphila DSM 22959 genome was screened using available databases and bioinformatics tools to identify putative antimicrobial resistance genes (ARG), virulence factors (VF), genomic islands (GI), and mobile genetic elements (MGE). The same categorization was obtained for both phenotypic methods. Resistance phenotype was observed for gentamicin, kanamycin, streptomycin, and ciprofloxacin, which was supported by the genomic context. No evidence was found of horizontal acquisition or potential transferability of the identified ARG and VF. Thus, this study provides new insights regarding the phenotypic and genotypic antimicrobial susceptibility profiles of the probiotic candidate A. muciniphila DSM 22959.
Keywords: Akkermansia muciniphila; antimicrobial resistance genes; antimicrobial susceptibility testing; in silico analysis; mobile genetic elements; safety profile.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin.Sci Rep. 2022 Nov 12;12(1):19426. doi: 10.1038/s41598-022-23980-6. Sci Rep. 2022. PMID: 36371559 Free PMC article.
-
Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677.Int J Food Microbiol. 2022 Feb 16;363:109501. doi: 10.1016/j.ijfoodmicro.2021.109501. Epub 2021 Dec 13. Int J Food Microbiol. 2022. PMID: 34953344
-
Comparative Genomics Revealed Wide Intra-Species Genetic Heterogeneity and Lineage-Specific Genes of Akkermansia muciniphila.Microbiol Spectr. 2022 Jun 29;10(3):e0243921. doi: 10.1128/spectrum.02439-21. Epub 2022 May 10. Microbiol Spectr. 2022. PMID: 35536024 Free PMC article.
-
A next generation probiotic, Akkermansia muciniphila.Crit Rev Food Sci Nutr. 2019;59(19):3227-3236. doi: 10.1080/10408398.2018.1517725. Epub 2018 Oct 29. Crit Rev Food Sci Nutr. 2019. PMID: 30373382 Review.
-
Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut-Liver-Brain Axes?Int J Mol Sci. 2023 Feb 15;24(4):3900. doi: 10.3390/ijms24043900. Int J Mol Sci. 2023. PMID: 36835309 Free PMC article. Review.
Cited by
-
Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases.Front Microbiol. 2024 Feb 6;15:1354447. doi: 10.3389/fmicb.2024.1354447. eCollection 2024. Front Microbiol. 2024. PMID: 38384263 Free PMC article. Review.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
-
Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin.Sci Rep. 2022 Nov 12;12(1):19426. doi: 10.1038/s41598-022-23980-6. Sci Rep. 2022. PMID: 36371559 Free PMC article.
References
-
- Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Scope and Appropriate Use of the Term Probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. doi: 10.1038/nrgastro.2014.66. - DOI - PubMed
-
- Yang M., Bose S., Lim S., Seo J., Shin J., Lee D., Chung W.-H., Song E.-J., Nam Y.-D., Kim H. Beneficial Effects of Newly Isolated Akkermansia Muciniphila Strains from the Human Gut on Obesity and Metabolic Dysregulation. Microorganisms. 2020;8:1413. doi: 10.3390/microorganisms8091413. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
